2 completed, 2 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 2 |
Follow neratinib: new trials by email Literature Review of neratinib trials Research Report on neratinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Medicine for Advanced Biliary Cancer Patients Futibatinib, Ivosidenib, Zanidatamab - Biliary Tract Neoplasms | Phase 3 | Recruiting | UNICANCER | 800 | 2024-07-18 | 2026-05-19 |
| Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab Trastuzumab and neratinib, Trastuzumab and Pertuzumab - Early-stage Breast Cancer, HER2-positive Breast Cancer | Phase 3 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 300 | 2023-03-14 | 2025-09-25 |
| A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting neratinib, capecitabine, lapatinib - HER2+ Metastatic Breast Cancer (MBC) | Phase 3 | Completed | Puma Biotechnology, Inc. | 621 | 2013-03-29 | 2021-06-11 |
| Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer neratinib, placebo - Breast Cancer | Phase 3 | Completed | Puma Biotechnology, Inc. | 2840 | 2009-07-09 | 2021-06-11 |
Breast Neoplasms (2) · Biliary Tract Neoplasms (1)
Puma Biotechnology, Inc. (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · UNICANCER (1)
Belgium (3) · France (3) · United Kingdom (3) · Australia (2) · Brazil (2) · Canada (2) · China (2) · Czechia (2) · Denmark (2) · Germany (2) · Hong Kong (2) · Israel (2) · Italy (2) · Japan (2) · Netherlands (2)
Ivan Borbath, MD (1) · John Bridgewater, MD (1) · Juan W Valle (1) · Julien Edeline, MD (1) · Malka David, MD (1)
PMID 26874901, PMID 29146401, PMID 30689703, PMID 30813966, PMID 30867034, PMID 31140297, PMID 32678716, PMID 34553296, PMID 36898233